chrX-112660642-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000371968.8(LHFPL1):āc.466A>Gā(p.Asn156Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,207,096 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 44 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000371968.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LHFPL1 | NM_178175.4 | c.466A>G | p.Asn156Asp | missense_variant | 3/4 | ENST00000371968.8 | NP_835469.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LHFPL1 | ENST00000371968.8 | c.466A>G | p.Asn156Asp | missense_variant | 3/4 | 1 | NM_178175.4 | ENSP00000361036 | P1 | |
LHFPL1 | ENST00000478229.1 | n.227-11929A>G | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000160 AC: 18AN: 112362Hom.: 0 Cov.: 23 AF XY: 0.000203 AC XY: 7AN XY: 34522
GnomAD3 exomes AF: 0.0000438 AC: 8AN: 182701Hom.: 0 AF XY: 0.0000447 AC XY: 3AN XY: 67177
GnomAD4 exome AF: 0.000120 AC: 131AN: 1094734Hom.: 0 Cov.: 28 AF XY: 0.000103 AC XY: 37AN XY: 360224
GnomAD4 genome AF: 0.000160 AC: 18AN: 112362Hom.: 0 Cov.: 23 AF XY: 0.000203 AC XY: 7AN XY: 34522
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.466A>G (p.N156D) alteration is located in exon 3 (coding exon 2) of the LHFPL1 gene. This alteration results from a A to G substitution at nucleotide position 466, causing the asparagine (N) at amino acid position 156 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at